Integrative Physiology |
From the INSERM U621/IFR-14 (L.L., S.Y., L.H., A.-M.L.), UPMC-CHU Pitié-Salpêtrière, Paris, France; the Cardiovascular Research Center (F.d.M., R.J.H.), Massachusetts General Hospital and Harvard Medical School, Charlestown, Mass; INSERM EMI 0228/IFR-118, USTL (T.C.), Villeneuve dAscq, France; and the Service de Cytometrie IBAIC (M.H.), IFR-FR46, Université Paris-Sud, Faculté des Sciences, Orsay, France.
Correspondence to Anne-Marie Lompré, INSERM U621, Faculté de Médecine Pitié-Salpétrière, 91 bd de lHôpital, 75634 Paris Cedex 13, France. E-mail lompre{at}chups.jussieu.fr
Proliferation of vascular smooth muscle cells (VSMC) is a primary cause of vascular disorders and is associated with major alterations in Ca2+ handling supported by loss of the sarco/endoplasmic reticulum calcium ATPase, SERCA2a. To determine the importance of SERCA2a in neointima formation, we have prevented loss of its expression by adenoviral gene transfer in a model of balloon injury of the rat carotid artery. Two weeks after injury, the intima/media ratio was significantly lower in SERCA2a-infected than in injured noninfected or injured ß-galactosidaseinfected carotids (0.29±0.04 versus 0.89±0.19 and 0.72±0.14, respectively; P<0.05), and was comparable to that observed in control carotids (0.21±0.03). The pathways leading to proliferation were analyzed in serum-stimulated VSMC. Forced expression of SERCA2a arrested cell cycle at the G1 phase and prevented apoptosis. SERCA2a inhibits proliferation through inactivation of calcineurin (PP2B) and its target transcription factor NFAT (nuclear factor of activated T-cells) resulting in lowering of cyclin D1 and pRb levels. By using NFAT-competing peptide VIVIT, we showed that NFAT activity is strongly required to promote VSMC proliferation. In conclusion, we provide the first evidence that increasing SERCA2a activity inhibits VSMC proliferation and balloon injuryinduced neointima formation.
Key Words: vascular smooth muscle cell proliferation gene transfer SERCA2a calcium signaling nuclear factor of activated T-cells
This article has been cited by other articles:
![]() |
R. Berra-Romani, A. Mazzocco-Spezzia, M. V. Pulina, and V. A. Golovina Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture Am J Physiol Cell Physiol, September 1, 2008; 295(3): C779 - C790. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. House and H. A. Singer CaMKII-{delta} Isoform Regulation of Neointima Formation After Vascular Injury Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 441 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Lipskaia, C. Pinet, Y. Fromes, S. Hatem, I. Cantaloube, A. Coulombe, and A.-M. Lompre Mutation of {delta}-Sarcoglycan Is Associated with Ca2+-Dependent Vascular Remodeling in the Syrian Hamster Am. J. Pathol., July 1, 2007; 171(1): 162 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. House, R. G. Ginnan, S. E. Armstrong, and H. A. Singer Calcium/calmodulin-dependent protein kinase II-{delta} isoform regulation of vascular smooth muscle cell proliferation Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2276 - C2287. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ying, X. Tong, D. R. Pimentel, R. M. Weisbrod, M. P. Trucillo, T. Adachi, and R. A. Cohen Cysteine-674 of the Sarco/Endoplasmic Reticulum Calcium ATPase Is Required for the Inhibition of Cell Migration by Nitric Oxide Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 783 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Nilsson, Z.-W. Sun, J. Nilsson, I. Nordstrom, Y.-W. Chen, J. D. Molkentin, D. Wide-Swensson, P. Hellstrand, M.-L. Lydrup, and M. F. Gomez Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1167 - C1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Koledova and R. A. Khalil Ca2+, Calmodulin, and Cyclins in Vascular Smooth Muscle Cell Cycle Circ. Res., May 26, 2006; 98(10): 1240 - 1243. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |